Opioid-Sparing Postoperative Pathway Effectively Controls Pain
By HospiMedica International staff writers Posted on 19 Jul 2019 |
A new study shows that over-the-counter painkillers can reduce and even eliminate opioid use following minor surgical procedures.
Researchers at the University of Michigan Health System (Ann Arbor, MI, USA) conducted a study involving 190 patients undergoing six surgical procedures, who were then offered the opportunity to participate in an opioid-sparing pain management pathway. The patients were advised to take a non-opioid pain reliever every three hours, alternating between 600 milligrams of ibuprofen and 650 mg of acetaminophen, and were provided with an opioid prescription (oxycodone), to be used if they experienced breakthrough pain.
They were then surveyed postoperatively regarding opioid use and patient-reported outcome measures. The results showed that 52% of the patients used no opioids after surgery, with almost all of them (91%) agreeing that their pain was manageable. Patients who did use opioids were younger, reported higher pain scores, received larger rescue prescriptions, and were less likely to agree that their pain was manageable. There were no other significant differences between opioid users and non-users. The study was published on May 31, 2019, in Journal of the American College of Surgeons (JACS).
“Up to 10% of patients who take opioids for the first time after an operation develop long-term dependence, and this risk of dependence has been found to be associated with the size of the initial prescription,” concluded study co-author Michael Englesbe, MD. “The fundamental concept is that we as surgeons and dentists are gatekeepers to opioid exposure. Most heroin users and people at risk of overdose got their first exposure to opioids from a medical care provider.”
Prescriptions of opioids for chronic pain have increased dramatically in the United States, a trend that has been accompanied by greatly increased levels of prescription opioid overdose, abuse, addiction, and diversion. While opioid therapy has been found to be associated with alleviation of pain in the short term, most opioid trials do not extend beyond six weeks, and are thus of limited relevance to long-term opioid use.
Related Links:
University of Michigan Health System
Researchers at the University of Michigan Health System (Ann Arbor, MI, USA) conducted a study involving 190 patients undergoing six surgical procedures, who were then offered the opportunity to participate in an opioid-sparing pain management pathway. The patients were advised to take a non-opioid pain reliever every three hours, alternating between 600 milligrams of ibuprofen and 650 mg of acetaminophen, and were provided with an opioid prescription (oxycodone), to be used if they experienced breakthrough pain.
They were then surveyed postoperatively regarding opioid use and patient-reported outcome measures. The results showed that 52% of the patients used no opioids after surgery, with almost all of them (91%) agreeing that their pain was manageable. Patients who did use opioids were younger, reported higher pain scores, received larger rescue prescriptions, and were less likely to agree that their pain was manageable. There were no other significant differences between opioid users and non-users. The study was published on May 31, 2019, in Journal of the American College of Surgeons (JACS).
“Up to 10% of patients who take opioids for the first time after an operation develop long-term dependence, and this risk of dependence has been found to be associated with the size of the initial prescription,” concluded study co-author Michael Englesbe, MD. “The fundamental concept is that we as surgeons and dentists are gatekeepers to opioid exposure. Most heroin users and people at risk of overdose got their first exposure to opioids from a medical care provider.”
Prescriptions of opioids for chronic pain have increased dramatically in the United States, a trend that has been accompanied by greatly increased levels of prescription opioid overdose, abuse, addiction, and diversion. While opioid therapy has been found to be associated with alleviation of pain in the short term, most opioid trials do not extend beyond six weeks, and are thus of limited relevance to long-term opioid use.
Related Links:
University of Michigan Health System
Latest Critical Care News
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia
- AI-Driven Prediction Models Accurately Predict Critical Care Patient Deterioration
- Preventive PCI for High-Risk Coronary Plaques Reduces Cardiac Events
- AI Diagnostic Tool Guides Rapid Diagnosis and Prediction of Sepsis
- World's First AI-Powered Sepsis Alert System Detects Sepsis in One Minute
- Smartphone Magnetometer Uses Magnetized Hydrogel to Measure Biomarkers for Disease Diagnosis
- New Technology to Revolutionize Valvular Heart Disease Care